140 related articles for article (PubMed ID: 21209960)
1. Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British Columbia.
Morgan SG; Cunningham CM; Hanley GE
PLoS One; 2010 Dec; 5(12):e15883. PubMed ID: 21209960
[TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data.
Morgan S; Hanley G; Cunningham C; Quan H
Open Med; 2011; 5(2):e87-93. PubMed ID: 21915239
[TBL] [Abstract][Full Text] [Related]
3. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
Hanley GE; Morgan S
Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
[TBL] [Abstract][Full Text] [Related]
4. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
5. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
[TBL] [Abstract][Full Text] [Related]
6. Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.
Enns B; Min JE; Panagiotoglou D; Montaner JSG; Nosyk B;
BMC Health Serv Res; 2019 Sep; 19(1):626. PubMed ID: 31481056
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic and Demographic Characteristics of US Adults Who Purchase Prescription Drugs From Other Countries.
Hong YR; Hincapie-Castillo JM; Xie Z; Segal R; Mainous AG
JAMA Netw Open; 2020 Jun; 3(6):e208968. PubMed ID: 32579194
[TBL] [Abstract][Full Text] [Related]
8. High-Cost Users of Prescription Drugs: A Population-Based Analysis from British Columbia, Canada.
Weymann D; Smolina K; Gladstone EJ; Morgan SG
Health Serv Res; 2017 Apr; 52(2):697-719. PubMed ID: 27087391
[TBL] [Abstract][Full Text] [Related]
9. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
Mendoza RL
J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
[TBL] [Abstract][Full Text] [Related]
10. Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada.
Hanley GE; Morgan S; Reid RJ
Med Care; 2010 May; 48(5):402-8. PubMed ID: 20393369
[TBL] [Abstract][Full Text] [Related]
11. Exploring the variation in state-level prescription utilization using a triangulation of analytic methods.
Hussein M; Brown LM
Res Social Adm Pharm; 2014; 10(6):853-866. PubMed ID: 24666607
[TBL] [Abstract][Full Text] [Related]
12. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada.
Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG
Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status, access to health care, and outcomes after acute myocardial infarction in Canada's universal health care system.
Pilote L; Tu JV; Humphries K; Behouli H; Belisle P; Austin PC; Joseph L
Med Care; 2007 Jul; 45(7):638-46. PubMed ID: 17571012
[TBL] [Abstract][Full Text] [Related]
14. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.
Gu Q; Dillon CF; Burt VL
NCHS Data Brief; 2010 Sep; (42):1-8. PubMed ID: 20854747
[TBL] [Abstract][Full Text] [Related]
15. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
Kennedy J; Morgan S
Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
[TBL] [Abstract][Full Text] [Related]
16. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
17. Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: evidence from Belgian prescription data.
Vrijens F; Van de Voorde C; Farfan-Portet MI; Vander Stichele R
Eur J Health Econ; 2012 Jun; 13(3):315-25. PubMed ID: 22139141
[TBL] [Abstract][Full Text] [Related]
18. Prescription of methylphenidate to children and youth, 1990-1996.
Miller AR; Lalonde CE; McGrail KM; Armstrong RW
CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
[TBL] [Abstract][Full Text] [Related]
19. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE; Morgan S; Hurley J; van Doorslaer E
Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
[TBL] [Abstract][Full Text] [Related]
20. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
